RecruitingPhase 3NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Sponsor: AstraZeneca
Kansas City, MO · St Louis, MO · +54 more sites
Obesity clinical trials in Kansas City, MO
12 recruiting obesity studies with a site in Kansas City, MO.
RecruitingPhase 3NCT07037433
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor: Amgen
City of Saint Peters, MO · Kansas City, MO · +137 more sites
RecruitingPhase 2NCT07282340
Phentermine's Impact on Treatment in Teens
Sponsor: Russell McCulloh, MD
Kansas City, MO · +7 more sites
RecruitingPhase 3NCT07684235
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Sponsor: Amgen
Kansas City, MO · +70 more sites
RecruitingPhase 1 / Phase 2NCT07123779
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Sponsor: 35Pharma Inc
Kansas City, MO · +1 more sites
RecruitingPhase 3NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Kansas City, MO · +22 more sites
RecruitingPhase 3NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Sponsor: AstraZeneca
Kansas City, MO · St Louis, MO · +51 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Kansas City, MO · +120 more sites
RecruitingPhase 1NCT04903223
Liver Adiposity Effects on Pediatric Statin
Sponsor: Children's Mercy Hospital Kansas City
Kansas City, MO
RecruitingPhase 1NCT07142707
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
Sponsor: MBX Biosciences
Kansas City, MO · +3 more sites
RecruitingPhase 2NCT06717698
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Sponsor: Novo Nordisk A/S
Kansas City, MO · +17 more sites
RecruitingPhase 2NCT05301413
Social Determinants and a Diabetes Prevention Program Tailored for African Americans
Sponsor: University of Missouri, Kansas City
Kansas City, MO
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.